Rocket Lab Just Signed the Biggest Launch Contract in the Company's History. But Is the Stock a Buy in 2026?

Rocket Lab signed 31 launch contracts in Q1, more than all of 2025, including its largest-ever launch deal, while backlog rose to a record $2.2 billion. First-quarter revenue increased 63.5% year over year to $200.3 million, though the company still posted a $45.0 million net loss and expects Q2 revenue of $225 million to $240 million. Management and analysts see profitability approaching next year as the company scales launch services and completes the Motiv acquisition.

Analysis

The market is increasingly pricing RKLB less like a launch contractor and more like a vertically integrated defense/infrastructure platform. The key second-order effect is that backlog conversion, not headline launch count, should drive multiple expansion: a larger contract book gives management more pricing power on future missions, higher utilization across fixed launch infrastructure, and better financing optionality as the company moves toward Neutron commercialization. If Neutron execution is credible, the strategic value of owning launch plus spacecraft subsystems rises meaningfully versus pure-play launch peers.

The bigger beneficiary may be the broader space supply chain, especially component and services vendors that can ride Rocket Lab’s scaling without bearing launch execution risk. But the flip side is margin dilution risk from in-sourcing and M&A: Motive-style acquisitions can improve mission complexity and capture more wallet share, yet they also raise integration risk and could delay the path to operating leverage if management keeps prioritizing capability breadth over near-term profitability. That makes the next 2-3 quarters a proof point on whether revenue growth is finally outrunning fixed-cost absorption.

The consensus gap is that investors may be extrapolating contract momentum into a clean profitability inflection too quickly. The more likely base case is lumpy earnings with a better cash-flow trajectory only after Neutron ramps; until then, any delay in launch cadence, procurement slippage from government customers, or cost overruns on next-gen programs could compress the multiple sharply. Conversely, if management converts this quarter’s backlog into visible 12-month revenue coverage, the stock can re-rate further because the market has already accepted that this is a long-duration compounding story, not a near-term earnings story.

Key Decisions for Investors

• Maintain a tactical long RKLB position into the next two quarterly prints; upside is driven by backlog-to-revenue conversion and Neutron execution credibility, but size it as a high-beta industrial/defense growth name because any schedule slip can cut the multiple 20-30% quickly.
• Pair trade: long RKLB / short a basket of slower-moving traditional aerospace primes for 3-6 months. The thesis is that contract momentum and faster revenue growth should outpace legacy names, but cap the trade if RKLB backlog growth stops translating into guidance raises.
• Buy RKLB call spreads 6-9 months out rather than outright stock if entering after a gap-up; this captures a rerating on contract/newsflow while defining risk around launch delays and M&A integration.
• For more conservative exposure to the space theme, consider a basket long in enabling suppliers/adjacent defense tech instead of pure launch risk, since the second-order winner is often the picks-and-shovels layer rather than the launcher itself.
• Set a hard risk trigger: if the next 1-2 quarters show revenue growth decelerating while losses remain sticky, reduce exposure aggressively, because the current narrative only works if operating leverage starts to show before Neutron spending escalates again.